Armata Pharmaceuticals, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001104659-26-060333
- Form type
- 10-Q
- CIK
- 0000921114
- Primary document
- https://www.sec.gov/Archives/edgar/data/921114/000110465926060333/armp-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Armata Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-8.8M | - | - |
| Net Income | $-115.3M | - | - |
| Eps Basic | -3.16 | - | - |
| Eps Diluted | -3.16 | - | - |
| Cash And Equivalents | $4.8M | - | - |
| Total Assets | $69.8M | - | - |
| Total Liabilities | $381.4M | - | - |
| Shareholders Equity | $-311.6M | - | - |
| Operating Cash Flow | $-5.8M | - | - |
| Capital Expenditures | $63,000 | - | - |